- Number of people
- 495 (49.09% female)
- People with ≥2 records
- 59.80%
- Median duration from first to last measurement
- 1.39 years
Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
Coding
Definition
- OMOP Concept ID
- 36305075— open in OHDSI Athena.
- Part of collection
- Vedolizumab with 0 other OMOP concept — open in OHDSI Athena.
OMOP mapping QC
| OMOP concept ID | Test name | Measurement unit (harmonized unit) | N people | N records | Missing measurement value | Harmonized value distribution |
Test outcome
NA
N
A
AA
L
LL
H
HH
|
|---|---|---|---|---|---|---|---|
| 36305075 | s-vedol | mg/l (mg/l) | 466 | 1324 | 0.00% |
|
|
| 36305075 | s-vedol | — (—) | 118 | 218 | 100.00% | Distribution not available |
Cohort
- Number of people
- 495 (49.09% female)
Year of birth distribution
Age at first measurement
Age at last measurement
Age at start of registry
Duration from first to last measurement
Statistics
- People with ≥2 records
- 59.80%
- Median number of measurements per person
- 2.0
- Median duration from first to last measurement
- 1.39 years